Business
Gamida Cell develops cellular and immune therapies for the treatment of cancer and orphan genetic diseases.
Hi, what are you looking for?
Gamida Cell develops cellular and immune therapies for the treatment of cancer and orphan genetic diseases.
Teva says it will seek ‘further appellate review’
– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the...
– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. – Drug development...
– Leading Israeli Pharmaceutical company Teva has mixed results in its initial U.S. Supreme Court hearing over the possible loss of patent protection for...
– – Gamida Cell’s main investors may sell all their holdings to Novartis at a later stage. – The deal for the sale...
Chiasma: The product is good. This was a strategic decision by Roche to be less involved in hormone-based drugs. – Roche AG (SWX:...
– Novartis had signed an MOU to acquire the stem cell treatment company for up to $600 million. – Elbit Medical Technologies Ltd. (TASE:EMTC)...
– Credit Suisse sees Copaxone sales falling from $4 billion annually to $400, 000 in 2019 and predicts annual sales of over $1 billion...
– / By Itzhak Dannon / Novartis Animal Health (U.S.), an American corporation that manufactures and distributes medication and treatments for animals is sued...